Joanna Shields

Veon, Inc. provides connectivity and digital services. The American company was founded by Yossi Hermush.

TalkTalk Telecom Group Ltd. provides telecommunications services to consumers and business to business customers in the United Kingdom. It offers fiber, broadband, landline, TV, and mobile services under the TalkTalk and TalkTalk Business brands. Its products include HomeSafe, a home filtering service for residential customers; WorkSafe that provides protection for internet devices to business customers; SuperSafe, which offers protection from viruses and malwares; CallSafe, a security feature that screens inbound calls; and TalkSafe, a way of identifying a customer when they call using their voice. The company was founded by Charles William Dunstone in 2002 and is headquartered in Salford, the United Kingdom.

The American School in London Educational Trust Ltd. engages in the administraton of charity and operation of school for boys and girls between four and eighteen years old. The company was founded by Stephen L. Eckard in 1951 and is headquartered in London, the United Kingdom.

Part of BenevolentAI SA, BenevolentAI Ltd. develops artificial intelligence applications. The company is based in London, UK. The British company was founded in 2015 by Kenneth Patrick Mulvany, Ivan Griffin, Michael Brennan. BenevolentAI was acquired by Odyssey Acquisition SA on April 22, 2022 for $1,087.33 million.

Part of BenevolentAI SA, BenevolentAI Technology Ltd. is a leading, clinical-stage AI-enabled drug discovery and British development company. Founded in 2005, the company is based in London, UK. From target identification through to clinical development, their AI-enabled Benevolent Platform™ augments scientific ingenuity, with the goal of improving the probability of clinical success. The company uses AI to empower scientists to uncover new insights from data, helping to accelerate innovation and increase the probability of discovering a successful drug. The company uses machine learning to generate new insights into the underlying causes of disease and capture these insights in their knowledge graph to support drug discovery and development. In 2022, they refined and formalized their approach to sustainability, under the direction of the newly established environmental, social and governance (ESG) governance structure and teams.